aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]
- RxCUI
- 1247397
- RxNorm name
- aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]
- Display name
- BC ARTHRITIS (Oral Powder)
- Full name
- aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]
- Term type
- SBD
- Status
- Active
- Strength
- 1,000-65 mg
- Dose form
- Pwdr
- Route
- Oral Powder
- Updated
- 2026-07-19 06:53:04
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042012
- Active start
- 042012
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Powder | 346289 |
Derived Ingredient Concepts#
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | ASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis] | NAMES |
| RxNorm Name | aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis] | NAMES |
| RxNorm Synonym | ASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis] | NAMES |
| RxNorm Synonym | BC Arthritis (ASA 1000 MG / caffeine 65 MG) Oral Powder | NAMES |
| TTY | SBD | ATTRIBUTES |
| SPL_SET_ID | 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | CODES |
| RxCUI | 1247397 | CODES |
| MMSL_CODE | BD27328 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 63029-990-02 | 63029-990 | BC Arthritis Aspirin and Caffeine | Medtech Products Inc. | M013 |
| 63029-990-06 | 63029-990 | BC Arthritis Aspirin and Caffeine | Medtech Products Inc. | M013 |
| 63029-990-50 | 63029-990 | BC Arthritis Aspirin and Caffeine | Medtech Products Inc. | M013 |
Drugs@FDA Applications#
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | BC Arthritis (ASA 1000 MG / caffeine 65 MG) Oral Powder | SY | 3 | BC Arthritis - 63029-990 | 20251023 |
| 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | BC Arthritis 1000 MG / 65 MG Oral Powder | PSN | 3 | BC Arthritis - 63029-990 | 20251023 |
| 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis] | SBD | 3 | BC Arthritis - 63029-990 | 20251023 |
| 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | ASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis] | SY | 3 | BC Arthritis - 63029-990 | 20251023 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | BC Arthritis - 63029-990 | Medtech Products Inc. | 20251023 |
| 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | BC Arthritis - 63029-990 | Medtech Products Inc. | 20241025 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AD | Other agents for local oral treatment | ATC1-4 | aspirin | |
| ATC | D11AX | Other dermatologicals | ATC1-4 | caffeine | |
| ATC | B01AC | Platelet aggregation inhibitors excl. heparin | ATC1-4 | aspirin | |
| ATC | N02BA | Salicylic acid and derivatives | ATC1-4 | aspirin | |
| ATC | N06BC | Xanthine derivatives | ATC1-4 | caffeine | |
| FDASPL | D014970 | Xanthines | CHEM | has_chemical_structure | caffeine |
| FDASPL | N0000175739 | Central Nervous System Stimulant | EPC | has_epc | caffeine |
| FDASPL | N0000175790 | Methylxanthine | EPC | has_epc | caffeine |
| FDASPL | N0000175722 | Nonsteroidal Anti-inflammatory Drug | EPC | has_epc | aspirin |
| FDASPL | N0000175578 | Platelet Aggregation Inhibitor | EPC | has_epc | aspirin |
| FDASPL | N0000175729 | Central Nervous System Stimulation | PE | has_pe | caffeine |
| MEDRT | D001241 | Aspirin | CHEM | has_ingredient | aspirin |
| MEDRT | D002110 | Caffeine | CHEM | has_ingredient | caffeine |
| MEDRT | D001049 | Apnea | DISEASE | may_treat | caffeine |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | aspirin |
| MEDRT | D001778 | Blood Coagulation Disorders | DISEASE | ci_with | aspirin |
| MEDRT | D001791 | Blood Platelet Disorders | DISEASE | ci_with | aspirin |
| MEDRT | D002544 | Cerebral Infarction | DISEASE | may_prevent | aspirin |
| MEDRT | D002644 | Chickenpox | DISEASE | ci_with | aspirin |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | aspirin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | aspirin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | caffeine |
| MEDRT | D005221 | Fatigue | DISEASE | may_treat | caffeine |
| MEDRT | D005334 | Fever | DISEASE | may_treat | aspirin |
| MEDRT | D006073 | Gout | DISEASE | may_treat | aspirin |
| MEDRT | D006396 | Hematemesis | DISEASE | ci_with | aspirin |
| MEDRT | D006474 | Hemorrhagic Disorders | DISEASE | ci_with | aspirin |
| MEDRT | D007223 | Infant | DISEASE | ci_with | aspirin |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | aspirin |
| MEDRT | D002546 | Ischemic Attack, Transient | DISEASE | may_prevent | aspirin |
| MEDRT | D008551 | Melena | DISEASE | ci_with | aspirin |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | may_prevent | aspirin |
| MEDRT | D009298 | Nasal Polyps | DISEASE | ci_with | aspirin |
| MEDRT | D010003 | Osteoarthritis | DISEASE | may_treat | aspirin |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | aspirin |
| MEDRT | D010146 | Pain | DISEASE | may_treat | aspirin |
| MEDRT | D011225 | Pre-Eclampsia | DISEASE | may_prevent | aspirin |
| MEDRT | D011263 | Pregnancy Trimester, Third | DISEASE | ci_with | aspirin |
| MEDRT | D012213 | Rheumatic Fever | DISEASE | may_treat | aspirin |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | aspirin |
| MEDRT | N0000000133 | Enzyme Inhibitors | MOA | has_moa | caffeine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | caffeine |
| MEDRT | N0000008331 | Cardiovascular Activity Alteration | PE | has_pe | caffeine |
| MEDRT | N0000008567 | Decreased Collecting Duct Water Permeability | PE | has_pe | caffeine |
| MEDRT | N0000008831 | Decreased Platelet Activating Factor Production | PE | has_pe | aspirin |
| MEDRT | N0000008832 | Decreased Platelet Aggregation | PE | has_pe | aspirin |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | aspirin |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | aspirin |
| MEDRT | N0000009197 | Increased Central Nervous System Organized Electrical Activity | PE | has_pe | caffeine |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | aspirin |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | aspirin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 1000 MG / 65 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SBD |
| CODES | MMSL_CODE | BD27328 |
| CODES | RxCUI | 1247397 |
| CODES | SPL_SET_ID | 3a85be2d-6548-4de5-8109-60e1ca2bfca3 |
| NAMES | Prescribable Synonym | BC Arthritis 1000 MG / 65 MG Oral Powder |
| NAMES | RXNAV_STR | ASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis] |
| NAMES | RxNorm Name | aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis] |
| NAMES | RxNorm Synonym | ASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis] |
| NAMES | RxNorm Synonym | BC Arthritis (ASA 1000 MG / caffeine 65 MG) Oral Powder |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |